natgillin/translations-raw huggingface dataset:
What Plavix is and what it is used for What you need to know before you take Plavix How to take Plavix 
Kaj je zdravilo Plavix in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Plavix Kako jemati zdravilo Plavix Možni neželeni učinki
Plavix 300 mg film-coated tablets This 300 mg tablet of clopidogrel is intended for use as a loading dose. 
Plavix 300 mg filmsko obložene tablete Ta 300 mg tableta klopidogrela je namenjena za uporabo kot udarni odmerek.
5 How to store Plavix Contents of the pack and other information 
Shranjevanje zdravila Plavix Vsebina pakiranja in dodatne informacije
PARTICULARS TO APPEAR ON BLISTERS (BLISTER / 7, 14, 28 or 84 tablets) 
PODATKI, KI MORAJO BITI NAJMANJ NAVEDENI NA PRETISNEM OMOTU (PRETISNI OMOT/ 7, 14, 28 ali 84 tablet)
- swelling in the mouth or skin disorders such as rashes and itching, blisters of the skin. 
- otekanje ust ali bolezni kože, kot so izpuščaj, srbenje in mehurji na koži.
Plavix is taken by adults to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death). 
Zdravilo Plavix jemljejo odrasli za preprečevanje nastanka krvnih strdkov (trombov) v otrdelih krvnih žilah (arterijah), proces je znan kot aterotromboza in lahko vodi do aterotrombotičnih dogodkov (kot so kap, srčni napad ali smrt).
However, clopidogrel and ASA have been administered together for up to one year (see section 
Vendar pa so klopidogrel in ASA uporabljali sočasno do enega leta (glejte poglavje 5.1).
Jaundice; severe abdominal pain with or without back pain; fever, breathing difficulties sometimes associated with cough; generalised allergic reactions (for example, overall sensation of heat with sudden general discomfort until fainting); swelling in the mouth; blisters of the skin; skin allergy; sore mouth (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscular pain; changes in taste or loss of taste of food. 
Zlatenica, huda bolečina v trebuhu z ali brez bolečine v hrbtu, zvišana telesna temperatura, težave pri dihanju, ki so včasih povezane s kašljem, splošne alergijske reakcije (na primer, splošni občutek toplote z nenadnim nelagodjem do nezavesti), oteklina v ustih, mehurji na koži, kožna alergija, vnetje v ustih (stomatitis), znižanje krvnega tlaka, zmedenost, halucinacije, bolečine v sklepih, bolečine v mišicah, motnje v okušanju ali izguba okusa hrane.
You have been prescribed Plavix to help prevent blood clots and reduce the risk of these severe events because: - You have a condition of hardening of arteries (also known as atherosclerosis), and - You have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease, or - You have experienced a severe type of chest pain known as ‘unstable angina' or ‘myocardial infarction' (heart attack). 
Zravilo Plavix vam je predpisan za pomoč pri preprečevanju nastajanja krvnih strdkov in za zmanjšanje tveganja teh hudih dogodkov, ker: - imate stanje otrdelih arterij (znano tudi kot ateroskleroza), in - ste predhodno doživeli srčni napad, kap ali imeli stanje, ki je znano kot periferna arterijska bolezen, ali - ste doživeli hudo obliko bolečine v prsih, znano kot “nestabilna angina” ali “miokardni infarkt” (srčni napad).
PVC/PVDC/Aluminium blisters or all aluminium blisters in cardboard cartons containing 7, 14, 28, 30, 84, 90 and 100 film-coated tablets. 
PVC/PVDC/aluminijasti pretisni omoti ali pretisni omoti iz aluminija, ki vsebujejo 7, 14, 28, 30, 84, 90 in 100 filmsko obloženih tablet.
For the 7, 14, 28 and 84 tablets pack sizes, you can check the day on which you last took a tablet of Plavix by referring to the calendar printed on the blister. 
Na koledarčku, ki je natisnjen na pretisnem omotu pri pakiranjih po 7, 14, 28 in 84 tablet, lahko preverite, kateri dan ste zadnjič vzeli tableto zdravila Plavix.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. 
Obvestite svojega zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katerokoli drugo zdravilo.
Overall, 645 of 646 patients with ST-elevation-MI (STEMI) or non-ST-elevation-MI (NSTEMI) or unstable angina were analyzed (de-escalated DAPT (n=322); unchanged DAPT (n=323)). 
V celoti so analizirali 645 od 646 bolnikov z miokardnim infarktom z elevacijo ST spojnice (STEMI), miokardnim infarktom brez elevacije ST spojnice (NSTEMI) ali nestabilno angino pektoris (deeskalirano DAPT (n = 322), nespremenjeno DAPT (n = 323)).
Respiratory tract bleeding (haemoptysis, pulmonary haemorrhage), bronchospasm, interstitial pneumonitis, eosinophilic pneumonia 
Krvavitve v dihalih (hemoptiza, pljučna krvavitev), bronhospazem, intersticijski pnevmonitis, eozinofilna pljučnica
Rash, pruritus, skin bleeding (purpura) 
Modrice Izpuščaj, srbenje, kožne krvavitve (purpura)
De-escalation of P2Y12 Inhibitor Agents in Acute Coronary Syndrome Switching from a more potent P2Y12 receptor inhibitor to clopidogrel in association with aspirin after acute phase in Acute Coronary Syndrome (ACS) has been evaluated in two randomized investigatorsponsored studies (ISS) - TOPIC and TROPICAL-ACS - with clinical outcome data. 
Prehod z močnejšega zaviralca receptorjev P2Y12 na klopidogrel v kombinaciji z acetilsalicilno kislino po akutni fazi akutnega koronarnega sindroma (AKS) so ocenili v dveh randomiziranih, s strani raziskovalcev sponzoriranih študij (ISS - investigator-sponsored studies) - TROPIC in TROPICALACS - s podatki o kliničnih izidih.
Therefore, concomitant use of clopidogrel with ART boosted therapies should be discouraged. 
Zato odsvetujemo sočasno uporabo klopidogrela z okrepljenimi ART.
What Plavix looks like and contents of the pack 
Izgled zdravila Plavix in vsebina pakiranja
4x1 film-coated tablets 30x1 film-coated tablets 100x1 film-coated tablets 10x1 film-coated tablets 
4x1 filmsko obloženih tablet 30x1 filmsko obloženih tablet 100x1 filmsko obloženih tablet.
If you have experienced severe chest pain (unstable angina or heart attack), your doctor may give you 300 mg of Plavix (1 tablet of 300 mg or 4 tablets of 75 mg) once at the start of treatment. 
Če ste imeli hudo bolečino v prsih (nestabilna angina pektoris ali srčna kap), vam lahko zdravnik na začetku zdravljenja da enkrat 300 mg zdravila Plavix (eno 300-mg tableto ali štiri 75-mg tablete).
Do not use this medicine after the expiry date which is stated on the carton and on the blister, after EXP. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in pretisnem omotu poleg oznake EXP. Rok uporabnosti se izteče na zadnji dan navedenega meseca.
It is preferable not to take this product during pregnancy. 
Nosečnost in dojenje Priporočljivo je, da se tega zdravila v nosečnosti ne uporablja.
In particular, in a post-hoc analysis in 2,172 patients (17% of the total CURE population) who underwent stent placement (Stent-CURE), the data showed that clopidogrel compared to placebo, demonstrated a significant RRR of 26.2% favouring clopidogrel for the co-primary endpoint (CV death, MI, stroke) and also a significant RRR of 23.9% for the second co-primary endpoint (CV death, MI, stroke or refractory ischaemia). 
Zlasti post hoc analiza podatkov 2172 bolnikov (17 % celotne populacije CURE), ki so jim namestili žilno opornico (Stent-CURE), je ob klopidogrelu v primerjavi s placebom pokazala značilno, 26,2 % zmanjšanje RT za sestavljen primarni opazovani dogodek (srčnožilna smrt, miokardni infarkt, možganska kap) in tudi značilno, 23,9 % zmanjšanje RT za drug sestavljen primarni opazovani dogodek (srčno-žilna smrt, miokardni infarkt, možganska kap ali neodzivna ishemija).
Plavix may be taken with or without food. 
Zdravilo Plavix skupaj s hrano in pijačo Zdravilo Plavix lahko jemljete s hrano ali brez nje.
While you are taking Plavix: 
Ko jemljete zdravilo Plavix:
However, patients entered into clinical trials with clopidogrel received a variety of concomitant medicinal products including diuretics, beta blockers, ACEI, calcium antagonists, cholesterol lowering agents, coronary vasodilators, antidiabetic agents (including insulin), antiepileptic agents and GPIIb/IIIa antagonists without evidence of clinically significant adverse interactions. 
Vendar pa so bolniki, ki so bili vključeni v klinično preskušanje klopidogrela, prejemali sočasno različna zdravila, vključno z diuretiki, zaviralci adrenergičnih receptorjev beta, zaviralci angiotenzinske konvertaze (ACEI), kalcijevimi antagonisti, učinkovinami za zniževanje holesterola, koronarnimi vazodilatatorji, antidiabetiki (vključno z insulinom), antiepileptičnimi učinkovinami in antagonisti glikoproteina IIb/IIIa, brez dokazov o klinično pomembnih neželenih interakcijah.
Plavix is unlikely to affect your ability to drive or to use machines. 
Vpliv na sposobnost upravljanja vozil in strojev Ni verjetno, da bi zdravilo Plavix vplivalo na vašo sposobnost za vožnjo ali upravljanje strojev.
Refer to the storage conditions on the carton. 
Navodila za shranjevanje zdravila so na škatli.
As with other antiplatelet agents, clopidogrel should be used with caution in patients who may be at risk of increased bleeding from trauma, surgery or other pathological conditions and in patients receiving treatment with ASA, heparin, glycoprotein IIb/IIIa inhibitors or non-steroidal anti-inflammatory drugs (NSAIDs) including Cox-2 inhibitors, or selective serotonin reuptake inhibitors (SSRIs), or other medicinal products associated with bleeding risk such as pentoxifylline (see section 4.5). 
Kot pri drugih antitrombotikih, moramo klopidogrel uporabljati previdno pri bolnikih s tveganjem za povečano krvavitev zaradi poškodbe, kirurškega posega ali drugih patoloških stanj in pri bolnikih, ki so na zdravljenju z ASA, heparinom, zaviralci glikoproteina IIb/IIIa ali nesteroidnimi protivnetnimi zdravili (NSAIDs) vključno z zaviralci COX-2, ali s selektivnimi zaviralci privzema serotonina (SSRI), ali z drugimi zdravili, ki so povezana s tveganjem za krvavitve, kot je pentoksifilin (glejte poglavje 4.5).
How to take Plavix 
Kako jemati zdravilo Plavix
Sanofi Winthrop Industrie 1, rue de la Vierge Ambarès & Lagrave F-33565 Carbon Blanc cedex France 
Sanofi Winthrop Industrie 1, Rue de la Vierge Ambarès & Lagrave F-33565 Carbon Blanc cedex Francija
- efavirenz, or other anti-retroviral medicines (used to treat HIV infections), - carbamazepine, a medicine to treat some forms of epilepsy, - moclobemide, medicine to treat depression, - repaglinide, medicine to treat diabetes, - paclitaxel, medicine to treat cancer, - opioids: while you are treated with clopidogrel, you should inform your doctor before being prescribed any opioid (used to treat severe pain). 
HIV), - karbamazepin, zdravilo za zdravljenje nekaterih oblik epilepsije, - moklobemid, zdravila za zdravljenje depresije, - repaglinid, zdravilo za zdravljenje sladkorne bolezni, - paklitaksel, zdravilo za zdravljenje raka, - opioidi: preden vam zdravnik predpiše opioide (uporabljajo se za zdravljenje hude bolečine), ga morate obvestiti, da se zdravite s klopidogrelom.
− Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction): clopidogrel treatment should be initiated with a single 300-mg loading dose and then continued at 75 mg once a day (with acetylsalicylic acid (ASA) 75 mg-325 mg daily). 
Akutni koronarni sindrom brez elevacije ST spojnice (nestabilna angina ali miokardni infarkt brez Q zobca):zdravljenje moramo začeti z enkratnim udarnim odmerkom 300 mg klopidogrela in nadaljevati s 75 mg enkrat na dan (s 75 mg do 325 mg acetilsalicilne kisline (ASA) dnevno).
What you need to know before you take Plavix Do not take Plavix 
Kaj morate vedeti, preden boste vzeli zdravilo Plavix
• Adult patients suffering from acute coronary syndrome: - Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). 
akutni koronarni sindrom brez elevacije ST spojnice (nestabilna angina ali miokardni infarkt brez Q zobca), vključno z bolniki, katerim je bil vstavljen stent po perkutani koronarni intervenciji, v kombinaciji z acetilsalicilno kislino (ASA - acetylsalicylic acid).
Thrombocytopenia, leucopenia, eosinophilia 
Trombocitopenija, levkopenija, eozinofilija
Plavix is supplied in cardboard cartons containing 4x1, 10x1, 30x1 and 100x1 tablets in all aluminium perforated unit-dose blisters. 
Zdravilo Plavix je na voljo v škatlah, ki vsebujejo 4x1, 10x1, 30x1, in 100x1 tableto v perforiranih pretisnih omotih za enkratni odmerek, ki so v celoti iz aluminija.
Plavix is supplied in cardboard cartons containing: 7, 14, 28, 30, 84, 90 and 100 tablets in PVC/PVDC/Aluminium blisters or in all aluminium blisters 
Zdravilo Plavix je na voljo v škatlah, ki vsebujejo: - 7, 14, 28, 30, 84, 90 in 100 tablet v PVC/PVDC/alu pretisnih omotih ali v pretisnih omotih iz aluminija, - 50x1 tableta v PVC/PVDC aluminijastih pretisnih omotih ali v aluminijastih perforiranih pretisnih omotih za enkratni odmerek.
If any of the situations mentioned below apply to you, you should tell your doctor before taking Plavix: 
Opozorila in previdnostni ukrepi Če katerokoli od spodaj navedenih stanj velja za vas, morate o tem obvestiti svojega zdravnika, preden boste vzeli zdravilo Plavix:
Method of administration For oral use 
Način uporabe Za peroralno uporabo
Polishing agent: Carnauba wax 
Glazura: karnauba vosek.
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTER / 30, 50x1, 90 or 100 tablets 
PRETISNI OMOT / 30, 50x1, 90 ali 100 tablet
- signs of liver problems such as yellowing of the skin and/or the eyes (jaundice), whether or not associated with bleeding which appears under the skin as red pinpoint dots and/or confusion (see section 2 ‘Warnings and precautions'). 
To so lahko znaki redkega zmanjšanja števila določenih krvnih celic, - znaki jetrnih težav, kot je porumenelost kože in/ali oči (zlatenica), ki so lahko, ali pa ne, povezani s krvavitvijo, ki se pojavi pod kožo kot drobne rdeče pike, in/ali zmedenostjo (glejte poglavje 2 »Opozorila in previdnostni ukrepi«).
If you cut or injure yourself, it may take longer than usual for bleeding to stop. 
Če doživite podaljšanje krvavitve v času jemanja zdravila Plavix Če se urežete ali poškodujete, lahko traja dlje kot običajno, da se vam krvavitev ustavi.
Calendar days Mon 
Dnevi v tednu: Pon
Fifteen percent (15.0%) of patients in the clopidogrel group and 21.7% in the placebo group reached the primary endpoint, representing an absolute reduction of 6.7% and a 36 % odds reduction in favor of clopidogrel (95% CI: 24, 47%; p < 0.001), mainly related to a reduction in occluded infarct-related arteries. 
Primarni opazovani dogodek je bil opažen pri 15,0 % bolnikov v skupini s klopidogrelom in 21¸7 % bolnikov v skupini s placebom, kar predstavlja absolutno zmanjšanje za 6,7 % in 36 % zmanjšanje verjetnosti v prid klopidogrela (95% IZ od 24 % do 47 %; p<0,001) v glavnem zaradi zmanjšanja zaradi infarkta zamašenih arterij.
Excipients with known effect: Each film-coated tablet contains 12 mg of lactose and 13.2 mg of hydrogenated castor oil. 
Ena filmsko obložena tableta vsebuje 12 mg laktoze in 13,2 mg hidrogeniranega ricinusovega olja.
• if you have a risk of bleeding such as - a medical condition that puts you at risk of internal bleeding (such as a stomach ulcer). 
• če imate tveganje za krvavitev, kot je: - zdravstveno stanje s tveganjem za notranjo krvavitev (kot je rana na želodcu) - krvna motnja, zaradi katere ste bolj nagnjeni k notranji krvavitvi (krvavitev v tkivih, organih ali sklepih vašega telesa).
Patients were randomized to receive either prasugrel 5 or 10 mg/d (Days 0-14) (n=1306), or prasugrel 5 or 10 mg/d (Days 0-7) then de-escalated to clopidogrel 75 mg/d (Days 8-14) (n=1304), in combination with ASA (<100 mg/day). 
Bolnike so randomizirali bodisi na prejemanje prasugrela 5 ali 10 mg/dan (od 0. do 14. dne) (n = 1306) bodisi na prejemanje prasugrela 5 ali 10 mg/dan (od 0. do 7. dne) s poznejšim deeskaliranjem na 75 mg klopidogrela na dan (od 8. do 14. dne) (n = 1304) v kombinaciji z ASA (< 100 mg/dan).
Marketing Authorisation Holder and Manufacturers 
Imetnik dovoljenja za promet z zdravilom in izdelovalci
In the intention to treat analysis, 939 events were observed in the clopidogrel group and 1,020 events with ASA (relative risk reduction (RRR) 8.7%, [95% CI: 0.2 to 16.4]; p=0.045), which corresponds, for every 1,000 patients treated for 2 years, to 10 [CI: 0 to 20] additional patients being prevented from experiencing a new ischaemic event. 
939 dogodkov in v skupini, ki je prejemala ASA, 1.020 dogodkov (zmanjšanje relativnega tveganja (RT) 8,7 %, [95 % IZ: 0,2 do 16,4]; p=0,045), kar ustreza preprečevanju pojava novega ishemičnega dogodka na vsakih 1.000 bolnikov, zdravljenih 2 leti, dodatnim 10 [IZ: 0 do 20] bolnikom.
1, rue de la Vierge, Ambarès & Lagrave, F-33565 Carbon Blanc cedex, France 
1, Rue de la Vierge, Ambarès & Lagrave, F-33565 Carbon Blanc cedex , Francija
Contact your doctor or the nearest hospital emergency department because of the increased risk of bleeding. 
Če ste vzeli večji odmerek zdravila Plavix, kot bi smeli Zaradi povečanega tveganja krvavitve se posvetujte s svojim zdravnikom ali oddelkom najbližje bolnišnične nujne zdravniške pomoči.
EU/1/98/069/001 28 film-coated tablets in PVC/PVDC/Alu blisters EU/1/98/069/002 50x1 film-coated tablets in PVC/PVDC/Alu blisters EU/1/98/069/003 84 film-coated tablets in PVC/PVDC/Alu blisters EU/1/98/069/004 100 film-coated tablets in PVC/PVDC/Alu blisters EU/1/98/069/005 30 film-coated tablets in PVC/PVDC/Alu blisters EU/1/98/069/006 90 film-coated tablets in PVC/PVDC/Alu blisters EU/1/98/069/007 14 film-coated tablets in PVC/PVDC/Alu blisters EU/1/98/069/011 7 film-coated tablets in PVC/PVDC/Alu blisters EU/1/98/069/013 28 film-coated tablets in all aluminium blisters EU/1/98/069/014 50x1 film-coated tablets in all aluminium blisters EU/1/98/069/015 84 film-coated tablets in all aluminium blisters EU/1/98/069/016 100 film-coated tablets in all aluminium blisters EU/1/98/069/017 30 film-coated tablets in all aluminium blisters EU/1/98/069/018 90 film-coated tablets in all aluminium blisters EU/1/98/069/019 14 film-coated tablets in all aluminium blisters EU/1/98/069/020 7 film-coated tablets in all aluminium blisters 
EU/1/98/069/001 28 filmsko obloženih tablet v PVC/PVDC/Alu pretisnih omotih EU/1/98/069/002 50x1 filmsko obloženih tablet v PVC/PVDC/Alu pretisnih omotih EU/1/98/069/003 84 filmsko obloženih tablet v PVC/PVDC/Alu pretisnih omotih EU/1/98/069/004 100 filmsko obloženih tablet v PVC/PVDC/Alu pretisnih omotih EU/1/98/069/005 30 filmsko obloženih tablet v PVC/PVDC/Alu pretisnih omotih EU/1/98/069/006 90 filmsko obloženih tablet v PVC/PVDC/Alu pretisnih omotih EU/1/98/069/007 14 filmsko obloženih tablet v PVC/PVDC/Alu pretisnih omotih EU/1/98/069/011 7 filmsko obloženih tablet v PVC/PVDC/Alu pretisnih omotih EU/1/98/069/013 28 filmsko obloženih tablet v aluminijastih pretisnih omotih EU/1/98/069/014 50x1 filmsko obloženih tablet v aluminijastih pretisnih omotih EU/1/98/069/015 84 filmsko obloženih tablet v aluminijastih pretisnih omotih EU/1/98/069/016 100 filmsko obloženih tablet v aluminijastih pretisnih omotih EU/1/98/069/017 30 filmsko obloženih tablet v aluminijastih pretisnih omotih EU/1/98/069/018 90 filmsko obloženih tablet v aluminijastih pretisnih omotih EU/1/98/069/019 14 filmsko obloženih tablet v aluminijastih pretisnih omotih EU/1/98/069/020 7 filmsko obloženih tablet v aluminijastih pretisnih omotih
If Plavix is supplied in PVC/PVDC/aluminium blisters, store below 30°C. 
Zdravilo Plavix, ki je na voljo v PVC/PVDC/alu pretisnih omotih, shranjujte pri temperaturi do 30C.
- ST segment elevation acute myocardial infarction: clopidogrel should be given as a single daily dose of 75 mg initiated with a 300-mg loading dose in combination with ASA and with or without thrombolytics. 
Akutni miokardni infarkt z elevacijo ST spojnice: klopidogrel je potrebno dajati v enkratnem dnevnem odmerku 75 mg, zdravljenje pa je potrebno začeti s 300 mg udarnim odmerkom v kombinaciji z ASA ter z/brez uporabe trombolitikov.
Bullous dermatitis (toxic epidermal necrolysis, Stevens Johnson Syndrome, erythema multiforme, acute generalised exanthematous pustulosis (AGEP)), angioedema, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms (DRESS), rash erythematous or exfoliative, urticaria, eczema, lichen planus 
Hypersensitivity Syndrome), kožni izpuščaj z eozinofilijo in sistemskimi simptomi, kot posledica zdravljenja z zdravilom (sindrom DRESS, Drug Rash with Eosinophilia and Systemic Symptoms), eritematozen ali eksfoliativen izpuščaj, urtikarija, ekcem, lihen planus
Thrombotic thrombocytopenic purpura (TTP) (see section 4.4), aplastic anaemia, pancytopenia, agranulocytosis, severe thrombocytopenia, acquired haemophilia A, granulocytopenia, anaemia 
Trombotična trombocitopenična purpura (TTP) (glejte poglavje 4.4), aplastična anemija, pancitopenija, agranulocitoza, huda trombocitopenija,
- If you are allergic (hypersensitive) to clopidogrel or any of the other ingredients of this medicine 
- če ste alergični na klopidogrel ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
Aluminium perforated unit-dose blisters in cardboard cartons containing 4x1, 10x1, 30x1 and 100x1 film-coated tablets. 
Aluminijski perforirani pretisni omoti za enkratni odmerek v kartonskih škatlah, ki vsebujejo 4 x 1, 10 x 1, 30 x 1 in 100 x 1 filmsko obloženo tableto.
Excipients with known effect: Each film-coated tablet contains 3 mg of lactose and 3.3 mg of hydrogenated castor oil. 
Ena filmsko obložena tableta vsebuje 3 mg laktoze in 3,3 mg hidrogeniranega ricinusovega olja.
Plavix 75-mg film-coated tablets are round, biconvex, pink, engraved on one side with the number ‘75' and on the other side with the number ‘1171'. 
Zdravilo Plavix 75 mg filmsko obložene tablete so okrogle, bikonveksne, rožnate tablete, z vtisnjeno številko “75” na eni strani in številko “1171” na drugi strani.
You should specifically tell your doctor if you take - medicines that may increase your risk of bleeding such as: o oral anticoagulants, medicines used to reduce blood clotting, o a non-steroidal anti-inflammatory medicine, usually used to treat painful and/or inflammatory conditions of muscle or joints, o heparin or any other injectable medicine used to reduce blood clotting, o ticlopidine, other antiplatelet agent, o a selective serotonin reuptake inhibitor (including but not restricted to fluoxetine or fluvoxamine), medicines usually used to treat depression, - omeprazole or esomeprazole, medicines to treat upset stomach, - fluconazole or voriconazole, medicines to treat fungal infections, 
Še posebej pomembno je, da obvestite svojega zdravnika, če jemljete - zdravila, ki lahko povečajo tveganje za krvavitve, kot so: o peroralni antikoagulanti, zdravila, ki preprečujejo nastanek krvnih strdkov, o nesteroidna protivnetna zdravila, ki se običajno uporabljajo za lajšanje bolečine in/ali vnetja mišic ali sklepov, o heparin, ali katerokoli drugo zdravilo v obliki injekcij, ki se uporablja za zmanjševanje strjevanja krvi, o tiklopidin, peroralno antiagregacijsko zdravilo, o selektivni zaviralci privzema serotonina (na primer fluoksetin ali fluvoksamin, a ne le tadva), ki se po navadi uporabljajo za zdravljenje depresije, - omeprazol ali ezomeprazol, zdravila za zdravljenje težav z želodcem,